Stonepine Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Stonepine Capital Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-509,356	Closed	-$1.02M	–	31
2019 Q3	$1.02M	Buy	+509,356	New	+$1.03M	0.99%	18
2019 Q1	–	Sell	-424,101	Closed	-$1.06M	–	35
2018 Q4	$1.06M	Sell	424,101 -474,056	-53%	-$1.58M	0.93%	17
2018 Q3	$3.61M	Sell	898,157 -1,031,865	-53%	-$4.55M	2.11%	14
2018 Q2	$7.29M	Sell	1,930,022 -1,311,528	-40%	-$3.42M	4.43%	8
2018 Q1	$7.52M	Buy	3,241,550 +45,858	+1%	+$72.5K	4.03%	9
2017 Q4	$4.95M	Buy	3,195,692 +328,907	+11%	+$528K	2.97%	13
2017 Q3	$6.11M	Buy	2,866,785 +1,271,236	+80%	+$4.32M	3.6%	12
2017 Q2	$7.21M	Sell	1,595,549 -1,161,711	-42%	-$4.21M	3.89%	12
2017 Q1	$8.3M	Sell	2,757,260 -401,556	-13%	-$1.18M	4.68%	9
2016 Q4	$8.72M	Buy	3,158,816 +1,240,094	+65%	+$3.55M	5.19%	8
2016 Q3	$6.01M	Buy	+1,918,722	New	+$7M	4.9%	7

Other funds holding CORV

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Stonepine Capital Management's CORV Position: Q4 2019 in Review

Stonepine Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 509,356 shares — an estimated $1.02M sold.

Stonepine Capital Management first reported a position in CORV in Q3 2016 and held it in 11 quarters. The position peaked at $8.72M in Q4 2016. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

Stonepine Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
Stonepine Capital Management sold 509,356 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $1.02M.
Stonepine Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2016 and held it in 11 quarters.
Stonepine Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $8.72M in Q4 2016.
31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Stonepine Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.